|Bid||1.2000 x 43500|
|Ask||1.2100 x 39400|
|Day's Range||1.1800 - 1.2800|
|52 Week Range||1.1000 - 3.5200|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 11, 2022 - Jul 15, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.89|
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So take...
As the cannabis market awaits a Senate vote on a legalization bill, these companies may not need it to succeed with investors
In an industry that sometimes seems like it is full of disappointment with continuous losses and lackluster growth numbers, cannabis investors received a welcome surprise last week from OrganiGram (NASDAQ: OGI). OrganiGram grew its sales and improved on its margins. Let's take a closer look at the numbers and see if OrganiGram is a pot stock worth buying today.